Medicare Advantage Organizations sometimes delayed or denied Medicare Advantage beneficiaries’ access to services, even though the prior authorization requests met Medicare coverage rules, according to a new report by the Office of the Inspector General.
Moderna announced today that it has submitted to the U.S. Food and Drug Administration a request for emergency use authorization for its COVID-19 vaccine to be given to children 6 months to under 2 years of age and for children 2 years to under 6 years…
In the Notice of Benefit and Payment Parameters for 2023 Final Rule released today, the Centers for Medicare and Medicaid Services is finalizing standards for issuers and insurers in the Affordable Care Act marketplaces, as well as requirements for age…
UnitedHealth Group intends to sell the claims editing business of Change Healthcare once it acquires Change, according to an April 22 filing with the Securities and Exchange Commission.
UnitedHealth Group has entered into an equity purchase agreement t…
Although hospitals see value in price transparency, a majority are concerned about significant challenges around deployment of CMS’ price transparency regulation, according to a KLAS survey of 66 revenue cycle leaders.
The regulation stipulates hospi…
The Department of Health and Human Services and other federal agencies have filed a notice to appeal a February ruling that affects the dispute resolution process in the No Surprises Act.
The American Hospital Association today released a new report showing rising input costs for hospitals over the past year for such expenses as
workforce, drugs, supplies and equipment.
House Democrats are calling on the Department of Health and Human Services to end so-called “junk plans.”
Optum has received approval from the Massachusetts Attorney General’s Office to go ahead with its planned purchase of Atrius Health.
The AG’s office has determined that, pending judicial review by the Massachusetts Supreme Court, Atrius Health has met …
Humana has signed a definitive agreement with private investment firm Clayton, Dubilier & Rice to divest a majority interest in Humana’s Kindred at Home subsidiary, KAH Hospice.
Under the agreement, Humana will divest a 60% interest in KAH Hospice and…
